Dry Granulation Excipients Market size is poised to reach USD 20 Billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of the dry granulation excipients was USD 12 Billion. The growth of dry granulation excipients growth is due to the burgeoning demand in the pharmaceutical and chemical industries. For instance, there are more than 20,000 pharmaceutical companies spread over more than 200 nations. Better stability and shelf life are provided for pharmaceutical formulations by dry granulation. The granules generated by dry granulation have improved chemical stability due to reduced exposure to moisture, making the finished product last longer and be of higher quality. Hence, over time dry granulation excipients have gained popularity in the pharmaceutical industry.
In addition, a high demand for generic drugs due to generic drugs having nominal pricing than branded drugs boosting the number of drugs sold in the market. Which would support the pharmaceutical industry and accelerate dry granulation excipients market expansion during the projection period.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~8% |
|
Base Year Market Size (2023) |
~ USD 12 Billion |
|
Forecast Year Market Size (2036) |
~ USD 20 Billion |
|
Regional Scope |
|
Formulation (Oral formulation, Tablets, Capsules)
The oral formulations segment in the dry granulation excipients market is estimated to gain the largest revenue share of about ~42% in the year 2036. The segment growth can be attributed to its wide usage and efficacy against various diseases. For instance, 361.3 million medications are administered or prescribed annually, and 76.2% of consultations involve drug therapy. This high usage of oral formulations can be attributed to their convenience, ease of administration, and patent compliance. Dry granulation excipients play a vital role in formulating these dosage forms, as a result driving growth in the oral formulation segment.
Product (Disintegrants & Lubricants, Organic Chemicals, Oleochemicals, Carbohydrates, Petrochemicals, and Others)
The lubricants and glidants in the dry granulation excipients market are estimated to gain a significant share of about ~18% in the year 2036. The segment growth can be attributed to the high utilization in manufacturing of oral solid dosage forms which are the most popular form of dosage. Lubricants and glidants play a crucial role in dry granulation by improving the flow properties of powders and reducing friction between particles and equipment surfaces. This leads to smoother processing, reduced equipment wear, and increased manufacturing efficiency, driving the demand for lubricants and glidants in the dry granulation excipient market.
Our in-depth analysis of the dry granulation excipient market includes the following segments:
|
Products |
|
|
Formulation |
|
|
End-User |
|
APAC Market Forecast
The dry granulation excipients market in the Asia Pacific region is anticipated to hold the largest share of about ~34% by the end of 2036. The market growth in the region is also expected on account of the rapidly expanding pharmaceutical industry in countries like China, Indonesia, India, Japan, and South Korea. Studies show that there are 3000 FDA-approved pharmaceutical companies in India additionally in South Korea, there were 653 pharmaceutical companies in 2022. This growth of the pharmaceutical industry can be attributed to the rising prevalence of chronic disease due to unhealthy lifestyles and high population rates in the region. Furthermore, countries in the Asia Pacific region like India which has one of the largest pharmaceutical industries in the world are hubs for generic drug manufacturing. This is due to the presence of major key players in the region, catering to both domestic and international markets. Dry granulation excipients are essential for formulating generic drugs, and the region's growing focus on generic pharmaceuticals contributes to the demand for these excipients.
European Market Analysis
The European dry granulation excipients market is estimated to be the second largest, registering a share of about ~24% by the end of 2036. The market’s expansion can be attributed majorly to the growing emphasis on superior generic pharmaceutical products due to economic pressure and healthcare cost containment efforts. For instance, currently, generic drugs account for around 50% of the European market by volume. Furthermore, the demand for oral solid dosage formulations in the region's growing aging population and the rising prevalence of chronic disease is also expected to propel the market growth. Moreover, the European region offers a conducive environment for the growth of the dry granulation excipient market, driven by stringent regulatory standards, increasing demand for oral solid dosage forms, advancements in pharmaceutical manufacturing, focus on patient compliance, high-quality drug delivery system, outsourcing trends, and innovation in drug delivery systems.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?